You are searching for: "Multiple myeloma"

---

T37539 Target Info	Target Name	B-cell receptor CD22 (CD22)
	Target type	Successful Target
	Disease	Haematological malignancy; Autoimmune diabetes;
	CAR T-Cell Therapy	CAR T-Cell Therapy Info

T56365 Target Info	Target Name	B-lymphocyte surface antigen B4 (CD19)
	Target type	Successful Target
	Disease	Scleroderma; Chronic lymphocytic leukaemia;
	CAR T-Cell Therapy	CAR T-Cell Therapy Info

T10877 Target Info	Target Name	Cyclic ADP-ribose hydrolase 1 (CD38)
	Target type	Successful Target
	Disease	Multiple myeloma; Haematological malignancy;
	CAR T-Cell Therapy	CAR T-Cell Therapy Info

T88023 Target Info	Target Name	Lymphocyte activation antigen CD30 (TNFRSF8)
	Target type	Successful Target
	Disease	Solid tumour/cancer; Lymphoma;
	CAR T-Cell Therapy	CAR T-Cell Therapy Info

T98052 Target Info	Target Name	SLAM family member 7 SLAMF7 (CS1)
	Target type	Successful Target
	Disease	Solid tumour/cancer; Multiple myeloma;
	CAR T-Cell Therapy	CAR T-Cell Therapy Info

T13017 Target Info	Target Name	Syndecan-1 (SDC1)
	Target type	Clinical trial Target
	Disease	Multiple myeloma; Immune System disease;
	CAR T-Cell Therapy	CAR T-Cell Therapy Info

T86323 Target Info	Target Name	Neural cell adhesion molecule 1 (NCAM1)
	Target type	Clinical trial Target
	Disease	Acute myeloid leukaemia; Myelodysplastic syndrome;
	CAR T-Cell Therapy	CAR T-Cell Therapy Info

T66693 Target Info	Target Name	B-cell maturation protein (TNFRSF17)
	Target type	Clinical trial Target
	Disease	Multiple myeloma; Chronic lymphocytic leukaemia;
	CAR T-Cell Therapy	CAR T-Cell Therapy Info

T82277 Target Info	Target Name	Cancer/testis antigen 1 (NY-ESO-1)
	Target type	Clinical trial Target
	Disease	Solid tumour/cancer; Melanoma;
	CAR T-Cell Therapy	CAR T-Cell Therapy Info

T35289 Target Info	Target Name	NKG2 D activating NK receptor (KLRK1)
	Target type	Clinical trial Target
	Disease	Multiple myeloma; Myelodysplastic syndrome;
	CAR T-Cell Therapy	CAR T-Cell Therapy Info

If you find any error in data or bug in web service, please kindly report it to Dr. Wang and Dr. Li.